Various alphabetized medical records

Life Sciences Intellectual Property

CRA has assisted clients in intellectual property (IP) matters concerning products and services in the life sciences sector, including Hatch-Waxman and BPCIA matters. We have also addressed patent, trademark, and copyright infringement, trade secret misappropriation, and IP licensing. Our experts have quantified damages based on lost profit and reasonable royalty methods and provided opinions on irreparable harm. In addition, we have experience addressing other forms of relief, such as rescission and disgorgement.

Our understanding of the unique dynamics of different therapeutic areas informs assessments of commercial success as a secondary indicator of non-obviousness and the claimed nexus between patented technologies and product success.


  • 01
    Valuation of contributions to codeveloped intellectual property
    CRA was retained to serve as a neutral advisor to the Tribunal in an international arbitration involving a licensing dispute between two agricultural sciences...
    View engagement
  • 02
    CRA analyses aid settlement discussion in trade secret theft allegation
    CRA was retained by the Plaintiff in a trade secrets litigation. CRA’s expert evaluated possible settlement options related to an alleged theft of trade...
    View engagement
  • 03
    Damages analysis and evaluation of commercial success for a medical device
    CRA was retained on behalf of the Plaintiff in a patent infringement matter involving collection devices used for diagnostic and genetic testing. Dr. Gregory...
    View engagement

Contact a Life Sciences Intellectual Property expert.

See all Life Sciences Intellectual Property experts

Subscribe to receive our latest Insights.